Dublin, Sept. 27, 2017 -- The "Branched Chain Amino Acids - A Global Market Overview" report has been added to Research and Markets' offering.
The global demand for Branched Chain Amino Acids (BCAAs) is projected to grow with a CAGR of 12% during 2017-22 period, driven by outstanding growth of L-valine in animal feed sector and sustained growth of three BCAAs in sports nutrition industry.
Ever since L-valine's introduction as the next limiting amino acid in protein diets for animals, demand for the same has been witnessing double digit growth rates and is further forecast to grow with a healthy 22% CAGR through the analysis period.
Europe leads the global volume market for BCAAs, estimated at 8.5 thousand metric tons (41.7% share) in 2017 while Asia-Pacific is anticipated to register the fastest similar period CAGR of 14.7% and reach a projected 12 thousand metric tons by 2022 from an estimated 6 thousand metric tons in 2017.
Research Findings & Coverage
- The global BCAAs market is analyzed in this report for its product segments and end-use applications
- Next Limiting Amino Acid L-Valine Fueling Growth for BCAAs in the Animal Feed Sector
- BCAA Enriched Foods Claimed to Extend Lifespan
- Key market trends including growth drivers and opportunities
- The report explores the market for end-use areas of all segments globally
- Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
- Major companies profiled - 48
- The industry guide includes the contact details for 227 companies.
Product Outline
The report analyzes the market for product segments of BCCAs including:
- L-Valine
- L-Leucine
- L-Isoleucine
- End-use applications of BCCAs analyzed comprise the following:
- Animal Feed
- Food & Beverages
- Pharma & Healthcare
- Nutraceuticals
- Cosmetics & Personal Care
Analysis Period & Units
The report reviews, analyzes and projects the global BCCAs market for the period 2012-2022 in terms of volume in metric tons, market value in US$ and the compound annual growth rates (CAGRs) projected from 2017 through 2022.
Geographic Coverage
- North America (The United States, Canada and Mexico)
- Europe (France, Germany, Italy, Russia, Spain, The United Kingdom and Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific)
- South America (Brazil and Rest of South America)
- Rest of World
Key Topics Covered:
Part A: Global Market Perspective
1. Introduction
2. Key Market Trends
3. Key Global Players
4. Key Business and Product Trends
5. Global Market Overview
Part B: Regional Market Perspective
Regional Market Overview
1. North America
2. Europe
3. Asia-Pacific
4. South America
5. Rest Of World
Part C: Guide to the Industry
Part D: Annexure
Companies Mentioned
- Ajinomoto Co., Inc.
- Amino GmbH
- Anhui Huaheng Biotechnology Co., Ltd.
- Biokyowa Inc. (United States)
- CJ Bio America (United States)
- CJ CheilJedang Corporation
- Daesang Corporation
- Evonik Corporation (United States)
- Evonik Industries AG
- Fufeng Group Company Limited
- Fuyang Dongchen Biological Engineering Co., Ltd.
- Henan Julong Bio-Engineering Co., Ltd.
- Iris Biotech GmbH (Germany)
- Jiangsu Xinhanling Biological Engineering Co., Ltd.
- Jinyao Ruida (Xuchang) Biology Technology Co., Ltd.
- Jizhou Huaheng Biological Technology Co., Ltd.
- Kyowa Hakko Bio Co., Ltd.
- Meihua Holdings Group Co., Ltd.
- Ningbo Create-Bio Engineering Co., Ltd.
- Ningbo Haishuo Biotechnology Co., Ltd.
- Nippon Rika Co., Ltd.
- Prinova Group LLC (United States)
- Sekisui Medical Co., Ltd. (Japan)
- Shaanxi Sciphar Hi-Tech Industry Co., Ltd.
- Shantou Jiahe Biological Technology Co., Ltd.
- Shijiazhuang Jirong Pharmaceutical Co., Ltd.
- Shijiazhuang Shixing Amino Acid Co., Ltd.
- Shine Star (Hubei) Biological Engineering Co., Ltd.
- Star Lake Bioscience Co., Inc. Zhaoqing Guangdong
- Sunrise Nutrachem Group
- Wuhan Grand Hoyo Co., Ltd.
- Wuxi Jinghai Amino Acid Co., Ltd.
- Yichang Sanxia Pharmaceutical Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/research/2cj9cn/branched_chain
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Oncology Drugs


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Instagram Outage Disrupts Thousands of U.S. Users
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Washington Post Publisher Will Lewis Steps Down After Layoffs
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



